Bacterial diseases have often magnified into epidemics, and this factor has led the medical research industry to heed to the cause.
Bacterial diseases have often magnified into epidemics, and this factor has led the medical research industry to heed to the cause. The presence of a stellar healthcare sector that focuses on minimizing the impact of plagues and viruses is a virtue for the world. However, the high incidence of diseases such as bacterial meningitis and pneumonia still haunts several regional territories. Therefore, the global pneumococcal vaccines market is slated to expand at a stellar pace in the following years.
Blood infections, in many cases, have claimed the lives of individuals of multiple age groups. This factor has generated a level of seriousness across the medical research fraternity. Furthermore, awareness campaigns and drives related to timely vaccinations has also played an integral role in the growth of the global market. The contagious nature of bacterial infections increases the likelihood of their occurrence across populated areas.
Improvements in Paediatric Care to Drive Demand
The field of paediatrics is closely related to pneumococcal vaccines. Children need to be vaccinated against several types of diseases, and this gives an impetus to market growth. Furthermore, the responsiveness of the masses towards a call for timely paediatric vaccinations has also driven market demand.
Spurt in cases of pneumococcal infections across underdeveloped countries has invited intervention from international authorities. The World Health Organisation (WHO) has taken pragmatic steps to promote vaccination across these regions. This factor has also bolstered the prospects of growth across the global pneumococcal vaccines market.
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=52146
High Incidence of Bacterial Diseases across Asia Pacific
The Asia Pacific region has been a victim to several disease outbreaks over the past decade. This factor has led to the generation of fresh revenues within the pneumococcal vaccines market, coming in from international entities. A senior researcher at Princeton University estimates that India faces the highest burden of pneumococcal pneumonia. This is also a key driver of demand within regional market for pneumococcal vaccines.
Market Segmentation
The global pneumococcal vaccines market has been segmented based on product type, distribution channel, sector, and region. In terms of product type, the global market has been classified into Synflorix, Prevenar-13, PCV 13 (pipeline), V114 (Merck), PCV-20 (Pfizer), PCV-10 (SII), and PPSV- 23. Each of the product segments has been divided into pediatric and adults. Based on distribution channel, the global market has been categorized into wholesalers (pharmacy channel), specialized companies, public authorities, and others. In terms of sector, the global pneumococcal vaccines market has been bifurcated into private and public. Based on region, the global market has been segmented into North America, Europe, Asia Pacific, Latin America, and Rest of the World.
Request Sample of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=52146
Pfizer, Inc. and Merck KGaA to Lead Market
The report also provides profiles of leading players operating in the global pneumococcal vaccines market. These include Pfizer, Inc., Merck & Co., Inc., SK Chemicals, Serum Institute of India Pvt., Ltd., Chengdu Institute of Biological Products Co., Ltd., GlaxoSmithKline plc, Sanofi, and Walvax Biotechnology Co., Ltd. Increase in mergers & acquisitions, strategic collaborations, and new product launches are expected to drive the global market during the forecast period. In September 2018, Pfizer, Inc. announced the grant of Breakthrough Therapy designation by the U.S. FDA for its pipeline candidate pneumococcal vaccine conjugate (20vPnC) - PF-06482077 for adults (18 years and above). Pfizer, Inc. plans to initiate phase-3 trials of the candidate by the end of 2018.
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.”
Contact
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
